The most common mistake healthcare technology leaders make when selecting a healthcare software development company is assuming that HIPAA-compliant software development and healthcare engineering expertise are the same thing. They are not. A vendor may be willing to sign a Business Associate Agreement (BAA), mention FHIR integration, HL7 interoperability, healthcare data security, and regulatory compliance in a proposal, and claim experience in healthcare application development, yet still lack the engineering capabilities required to protect PHI, implement production-grade healthcare interoperability, maintain immutable audit trails, support FDA-regulated software and Software as a Medical Device (SaMD) requirements, or build secure digital health platforms at scale. The gap between compliance claims and engineering capability is where many healthcare software development projects fail.
There is a version of this decision that most health tech leaders make and later regret. It goes roughly like this: the team looks impressive in the demo, the portfolio has 'healthcare' in several case study titles, the price is competitive, and the proposal uses the right words, HIPAA, FHIR, HL7, and compliance. Contract signed. Six months later, the engineering team discovers the development partner has never actually implemented SMART on FHIR in production. Or that their PHI masking strategy is database-level encryption, not masking. Or that their audit trail logs sessions, not individual row-level actions. Or worst of all, that they've been building in a production environment that contains real patient data.
These are not edge-case horror stories. They describe the gap between vendor claims and vendor capability that exists at most healthcare software development firms, most of the time. The gap exists because healthcare software development is genuinely hard, the regulatory environment is multi-layered, the technical standards are complex, and the consequences of getting it wrong are severe. Most generalist development firms don't encounter this environment until they're mid-project on your engagement.
This guide gives you 14 specific technical questions to ask before you sign anything. Each question maps to a real engineering capability requirement, not a legal compliance checkbox, and includes what a credible answer looks like and what a disqualifying answer sounds like.
In 2025, healthcare IT staffing shortages drove widespread project delays and burnout risks, with McKinsey projecting 200,000–450,000 nurse deficits alone. Over 80% of US healthcare leaders have deployed generative AI use cases for clinical/operational tasks, fueling reliance on external partners. McKinsey Gen AI Healthcare Survey Q4 2025
When you hire a development partner for a retail platform or a SaaS analytics tool, a failed project means lost time and money. When you hire a development partner to build a HIPAA-regulated healthcare product, a failed project can mean a federal investigation, civil monetary penalties between $100 and $50,000 per violation (up to $1.9 million per violation category per year), potential criminal charges for willful neglect, notification of every patient whose data was exposed, and reputational damage that can end a company.
Healthcare software development partners become your Business Associates under 45 CFR §164.308. That is a legal relationship, not a label. It means they are subject to the HIPAA Security Rule, they must execute a Business Associate Agreement before accessing any PHI, they must safeguard PHI with technical controls that meet the same standards as yours, and they bear direct legal liability for breaches that result from their failure.The technical evaluation criteria that follow are not abstract compliance boxes. Each one maps to a real engineering decision made early in architecture, deeply expensive to retrofit, that determines whether your product is defensible in a federal audit, whether your patients' data is actually protected, and whether your engineering team will spend the next 18 months building features or fixing compliance architecture.
Each criterion maps to a real engineering capability requirement — not a legal compliance checkbox. Use these as your opening framework in the first conversation with any vendor.
Before running this checklist against specific vendors, understand where each vendor type typically sits. Individual firms vary, but this reflects the pattern most health tech leaders encounter.
| Criterion | Generalist Agency | Healthcare-Specific Agency | NonStop.io |
|---|---|---|---|
| HIPAA BAA | Signs on request — legal template only | Yes, with standard technical controls | BAA + documented engineering safeguards before any PHI access |
| FHIR | May have some FHIR experience | R4 integration standard | R4/R4B/R5 + SMART on FHIR + Bulk FHIR + CDS Hooks; production Epic, Cerner, Athena |
| PHI Masking | Encryption treated as equivalent | Masking in non-production environments | Delphix deterministic masking; DataSunrise dynamic masking; Tonic.ai synthetic data for ML |
| AI Explainability | Black-box ML models standard | Mentions explainability in scoping | Model explainability by design; FDA AI/ML SaMD guidance-aligned; SHAP/LIME integration |
| FDA SaMD | No FDA product experience | May have completed one SaMD project | DHF documentation, IEC 62304 lifecycle compliance, 510(k) pre-submission preparation |
| Data Engineering | Separate engagement or not offered | Basic ETL and database integration | End-to-end: Databricks, Snowflake, Delta Lake, Kafka, Great Expectations |
| Audit Trail | Application-layer logging | Row-level logging | Row-level immutable logs (Delta Lake); Unity Catalog column access; OpenMetadata full lineage |
| Post-Launch | Ticket-based support model | SLA-based maintenance | Continuous PHI detection; schema change alerting; quarterly access control reviews |
The pattern is consistent: generalist agencies learn your compliance requirements on your timeline and your budget. Healthcare-specific agencies satisfy the standard compliance stack (HIPAA BAA, FHIR R4, PHI masking) but often lack the depth required for AI-powered products, life sciences subspecialty requirements, or data engineering sophistication. NonStop's practice is built specifically for the intersection of all three.
A Business Associate Agreement (BAA) is a legally binding contract required under HIPAA between a HIPAA-covered entity and any vendor who creates, receives, maintains, or transmits Protected Health Information on the covered entity’s behalf. A software development company that builds or operates a healthcare application that touches PHI qualifies as a Business Associate and must execute a BAA before accessing any patient data. The BAA specifies the permitted uses of PHI, requires the vendor to implement safeguards, and obligates the vendor to notify the covered entity of any PHI breach. Without a BAA, any PHI access by the development vendor constitutes a HIPAA violation.A production-ready clinical bioinformatics pipeline must be reproducible across runs, scalable for clinical sample volumes, auditable for regulatory compliance, and integrated with clinical systems such as LIMS and reporting platforms.
The HIPAA Security Rule specifies four categories of required technical safeguards. Access controls: each user must have a unique identifier, and access must be limited to the minimum necessary for their role. Audit controls: mechanisms must record and examine all activity in PHI-containing systems. Integrity controls: electronic mechanisms must confirm that PHI has not been improperly altered or destroyed. Transmission security: technical measures must protect PHI during electronic transmission, including encryption over open networks. Companies implementing only application-layer access controls, limited audit logging, or encryption without PHI masking in non-production environments still have compliance gaps.
FHIR (Fast Healthcare Interoperability Resources) is the HL7 standard for healthcare data exchange and the dominant US healthcare interoperability standard. FHIR defines a REST API and a standardized resource model that enable healthcare systems to exchange clinical data in a consistent, machine-readable format. The 21st Century Cures Act and ONC rules mandate FHIR R4 API access for certified EHR systems, making FHIR essential for products that integrate with major EHR platforms such as Epic, Cerner, and Athena. SMART on FHIR extends FHIR with OAuth 2.0-based authorization for secure data access.
SOC 2 is an AICPA auditing standard that evaluates controls across Security, Availability, Processing Integrity, Confidentiality, and Privacy. Type I is a point-in-time assessment showing that controls existed on a specific date. Type II covers an extended audit period and verifies that controls operated effectively and consistently over time. For healthcare software vendors with ongoing access to PHI environments, Type II provides stronger assurance than Type I.
FDA Software as a Medical Device (SaMD) is software intended for medical purposes, such as diagnosis, treatment, mitigation, or prevention of disease, that is not part of a hardware medical device. Products requiring FDA SaMD classification may include AI-powered diagnostic tools, AI/ML-based clinical decision support systems, risk-stratification algorithms, and digital therapeutics that deliver therapeutic benefit. Software development companies building these products without understanding FDA SaMD requirements cannot produce products eligible for US commercial deployment.
Data masking is an irreversible transformation that replaces PHI with realistic but fictitious data while preserving structural properties for testing and development. Because masking is irreversible, the original PHI cannot be reconstructed. Encryption is reversible and can be decrypted using an encryption key. HIPAA requires PHI in non-production environments to be protected with appropriate safeguards, making masking or synthetic data generation essential for healthcare software development. Deterministic masking ensures the same source PHI value always produces the same masked value, maintaining referential integrity across databases.
Healthcare software development cost varies by product type, compliance requirements, and integration scope. A HIPAA-compliant digital health application may cost $150,000–$400,000 for an MVP. A FHIR-native EHR integration platform may range from $300,000–$800,000. AI-powered clinical decision support systems with FDA SaMD documentation may cost $400,000–$1,200,000. A genomics data platform with CLIA compliance, LIMS integration, and ML infrastructure may exceed $2,000,000. Compliance architecture, audit trail infrastructure, and regulatory documentation can add 25–40% to total engineering cost.
NonStop.io’s healthcare engineering practice differs in three ways. First, compliance expertise is embedded directly into engineering rather than added later through consulting reviews. Second, data engineering is integrated with product engineering, enabling AI-powered healthcare products with FHIR-native pipelines, PHI-safe feature stores, and training data quality frameworks. Third, NonStop has depth in life sciences, including genomics data platforms, clinical diagnostics systems, and pharma R&D infrastructure, which many healthcare software companies lack.
